Pro und Kontra: „Jeder Schizophreniekranke sollte so früh wie möglich behandelt werden”

doi:10.1055/s-2005-915399

Psychiatrische Praxis, Inhaltsverzeichnis

Psychiatr Prax 2006; 33(3): 105-107
DOI: 10.1055/s-2005-915399

Debatte

Pro und Kontra: „Jeder Schizophreniekranke sollte so früh wie möglich behandelt werden”

For and Against: „Every Person with Schizophrenia Should be Treated as Early as Possible”

Abstract

Volltext

Referenzen

Literatur

1 WHO .Prevention of Mental Disorders. Effective Interventions and Policy Options. Summary Report. Geneva; World Health Organization 2005 http://www.who.int/mental_health/evidence/en/Prevention_of_Mental_Disorders.pdf
2 Philipps L J, McGorry P D, Yung A R, McGlashan T H, Cornblatt B, Klosterkötter J. Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities. Br J Psychiatry. 2005; 48, suppl 33-44
3 Ruhrmann S, Schultze-Lutter F, Klosterkötter J. Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry. 2003; suppl 3 162-167
4 Marshall M, Lewis S, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry. 2005; 62 975-983
5 McGorry P D, Yung A R, Philipps L J, Yuen H P, Francey S, Cosgrave E M, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002; 59 921-928
6 McGlashan T H, Zipursky R B, Perkins D O, Addington J, Woods S W, Miller T J, Lindborg S, Marquez E, Hawkins K, Hoffmann R E, Tohen M, Breier A. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. study rational and design. Schizophr Res. 2003; 61 7-18
7 Bechdolf A, Ruhrmann S, Wagner M, Kuhn K U, Janssen B, Bottlender R, Wieneke A, Schultze-Lutter F, Maier W, Klosterkötter J. Interventions in the initial prodromal states of psychosis in Germany: Concept and recruitment. Br J Psychiatry. 2005; 48, suppl 45-48
8 Morrison A P, French P, Walford L, Lewis S W, Kilcommons A, Green J, Parker S, Bentall R P. A randomised controlled trial of early detection and cognitive therapy for the prevention of psychosis in people at ultra-high risk. Br J Psychiatry. 2004; 185 291-297
9 Klosterkötter J, Hellmich M, Steinmeyer E M, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001; 58 158-164
10 Bechdolf A, Veith V, Klosterkötter J. Group therapy for people at high risk of developing psychosis. In: Addington, Francey, Morrison (eds) Working with people a high risk of developing psychosis: A treatment handbook. Chichester; John Wiley & Sons, Ltd. 2006
11 Bottlender R, Möller H-J. The impact of the duration of untreated psychosis on short- and long-term outcome in schizophrenia. Current Opinion in Psychiatry. 2003; 16, Supplement 2 39-43
12 Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005; 62 (9) 975-983
13 Gilmer T P, Dolder C R, Lacro J P, Folsom D P, Lindamer L, Garcia P, Jeste D V. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004; 161 (4) 692-699
14 Rose S, Bisson J, Wessely S. A systematic review of single-session psychological interventions („debriefing”) following trauma. Review. Psychother Psychosom. 2003; 72 (4) 176-184
15 Os J van, Wright P, Murray R. Follow-up studies of schizophrenia I: snatural history and non-psychopathological predictors of outcome. European Psychiatry. 1997; 12, Supplement 5 327s-341s
16 McGlashan T H, Miller T J, Woods S W. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull. 2001; 27 (4) 563-570
17 Os J van, Hanssen M, Bijl R V, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch Gen Psychiatry. 2001; 58 (7) 663-668
18 Warner R. Early intervention in schizophrenia: a critique. Epidemiologia e Psichiatria Sociale. 2002; 11, 4 248-255
19 Petersen L, Jeppesen P, Thorup A, Abel M B, Ohlenschlaeger J, Christensen T O, Krarup G, Jorgensen P, Nordentoft M. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ. 2005; 331 (7517) 602-605